Mortality trends in pulmonary arterial hypertension: Are we just spinning our wheels?
Open Access
- 1 October 2022
- journal article
- editorial
- Published by Wiley in Pulmonary Circulation
- Vol. 12 (4) , e12162
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The evolution of survival of pulmonary arterial hypertension over 15 yearsPulmonary Circulation, 2022
- 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Respiratory Journal, 2022
- Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline eraEuropean Respiratory Journal, 2021
- Temporal trends in pulmonary arterial hypertension: results from the COMPERA registryEuropean Respiratory Journal, 2021
- Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial HypertensionJACC, 2021
- Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2021
- Combination Therapy for Pulmonary Arterial Hypertension: A Systematic Review and Meta-analysisCanadian Journal of Cardiology, 2016
- Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysisThe Lancet Respiratory Medicine, 2016
- Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial HypertensionNew England Journal of Medicine, 2015
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996